Nantahala Capital Management, LLC Taysha Gene Therapies, Inc. Transaction History

Nantahala Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.59 - $0.87 $278,043 - $409,997	-471,261 Reduced 27.36%	1,251,139 $825,000
Q1 2023 May 15, 2023	SELL	$0.65 - $2.3 $830,287 - $2.94 Million	-1,277,365 Reduced 42.58%	1,722,400 $1.38 Million
Q4 2022 Feb 14, 2023	BUY	$1.39 - $2.98 $1.93 Million - $4.14 Million	1,388,943 Added 86.23%	2,999,765 $6.78 Million
Q3 2022 Nov 10, 2022	SELL	$1.76 - $4.94 $57,404 - $161,123	-32,616 Reduced 1.98%	1,610,822 $3.25 Million
Q2 2022 Aug 15, 2022	BUY	$2.47 - $6.77 $764,442 - $2.1 Million	309,491 Added 23.2%	1,643,438 $6.11 Million
Q1 2022 May 13, 2022	SELL	$5.22 - $11.86 $637,884 - $1.45 Million	-122,200 Reduced 8.39%	1,333,947 $8.7 Million
Q4 2021 Feb 14, 2022	BUY	$11.43 - $19.2 $2.36 Million - $3.97 Million	206,838 Added 16.56%	1,456,147 $17 Million
Q3 2021 Nov 15, 2021	BUY	$15.82 - $21.57 $12.9 Million - $17.6 Million	817,237 Added 189.14%	1,249,309 $23.3 Million
Q2 2021 Aug 16, 2021	BUY	$19.29 - $26.38 $7.62 Million - $10.4 Million	395,116 Added 1069.15%	432,072 $9.16 Million
Q1 2021 May 14, 2021	SELL	$20.3 - $31.75 $844,886 - $1.32 Million	-41,620 Reduced 52.97%	36,956 $750,000
Q4 2020 Feb 16, 2021	BUY	$19.14 - $28.13 $68,444 - $100,592	3,576 Added 4.77%	78,576 $2.09 Million
Q3 2020 Nov 16, 2020	BUY	$22.4 - $24.47 $1.68 Million - $1.84 Million	75,000 New	75,000 $1.68 Million

117

136M

25.9K

24K

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $85.1M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.